ici 118551 has been researched along with Ventricular Fibrillation in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altschuld, RA; Billman, GE; Castillo, LC; Hensley, J; Hohl, CM | 1 |
Altschuld, RA; Billman, GE | 1 |
Cuparencu, B; Cuprian, A; Gozariu, M; Tomus, C | 1 |
Altschuld, RA; Billman, GE; Houle, MS | 1 |
Johnston, RB; Murakami, MM; Salerno, DM | 1 |
Hohnloser, SH; Lown, B; Verrier, RL | 1 |
1 review(s) available for ici 118551 and Ventricular Fibrillation
Article | Year |
---|---|
Activation of beta 2-adrenergic receptors and ventricular fibrillation.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium; Clinical Trials as Topic; Dogs; Ethanolamines; Guinea Pigs; Heart; Heart Failure; Humans; Myocardium; Papio; Propanolamines; Ranidae; Rats; Receptors, Adrenergic, beta-2; Stimulation, Chemical; Ventricular Fibrillation | 1998 |
5 other study(ies) available for ici 118551 and Ventricular Fibrillation
Article | Year |
---|---|
Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium; Cells, Cultured; Cyclic AMP; Death, Sudden; Dogs; Ethanolamines; Exercise Test; Imidazoles; Isoproterenol; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardium; Propanolamines; Sensitivity and Specificity; Ventricular Fibrillation | 1997 |
Effects of ICI 118.551, a selective beta-2 adrenergic blocking agent on the guinea pig cardiac excitability and ventricular fibrillation threshold.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Pacing, Artificial; Female; Guanethidine; Guinea Pigs; Heart Conduction System; In Vitro Techniques; Male; Perfusion; Propanolamines; Sodium Glutamate; Ventricular Fibrillation | 2000 |
Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Dogs; Echocardiography; Heart Rate; In Vitro Techniques; Isoproterenol; Myocardial Infarction; Myocardium; Propanolamines; Ventricular Fibrillation | 2001 |
The effects of beta 1- and beta 2-adrenergic blockade and calcium channel blockade on postresuscitation electrolyte changes.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Calcium; Calcium Channel Blockers; Diltiazem; Dogs; Hemodynamics; Magnesium; Metoprolol; Potassium; Premedication; Propanolamines; Resuscitation; Time Factors; Ventricular Fibrillation; Water-Electrolyte Imbalance | 1992 |
Effects of adrenergic and muscarinic receptor stimulation on serum potassium concentrations and myocardial electrical stability.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Epinephrine; Female; Heart; Male; Methacholine Chloride; Methacholine Compounds; Metoprolol; Potassium; Propanolamines; Receptors, Adrenergic; Receptors, Muscarinic; Ventricular Fibrillation | 1986 |